Everyday Health climbs past WebMD

Share this article:
In the battle for unique visitors, Waterfront Media's Everyday Health has surpassed WebMD to lead the online consumer health space. 

Ben Wolin, CEO of Waterfront Media, told MM&M that the merger with Revolution Health in early October was a major factor in the company's ascension. Another factor, said Wolin, is that Everday Health—in keeping with its name—has constructed a portfolio of products that focus on daily health usage. “Our products, content and tools encourage visitors to come back daily—to check a pregnancy calendar, or to use a diet tool or diabetes tool, for example,” he said.

According to comScore's Media Metrix data, released in mid-November, Everyday Health garnered 25.7 million unique visitors in October, compared with 19.6 million for WebMD. In terms of average daily visitors, Everyday Health racked up 1.5 million during October, compared with WebMD's 1 million, according to comScore's Media Metrix.

WebMD announced the acquisition of the Quality Health Network in September, however. The Quality Health Network is positioned eighth in comScore's October unique visitor count, at 7.3 million. According to Peter Burch, VP of sales at QualityHealth.com, WebMD is currently undergoing due diligence for the acquisition, with the deal “closing any day now.” Burch said WebMD's numbers do not reflect Quality Health Network's unique visitor count. When the acquisition is finalized, the deal will “catapult [WebMD] ahead of Everyday Health,” said Burch. A combined total of Quality Health Network and WebMD's numbers for October would equal 26.9 million unique visitors, a full 1.2 million more visitors than Everyday Health's.

Waterfront Media's properties include the Everyday Health Network, Revolutionhealth.com, Carepages.com, WhatToExpect.com and 22 others. “We'll continue to grow the category,” said Wolin. “We've got lots of running room.” 
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"